Acute and chronic effects of treatment with mesenchymal stromal cells on LPS-induced pulmonary inflammation, emphysema and atherosclerosis development

BACKGROUND: COPD is a pulmonary disorder often accompanied by cardiovascular disease (CVD), and current treatment of this comorbidity is suboptimal. Systemic inflammation in COPD triggered by smoke and microbial exposure is suggested to link COPD and CVD. Mesenchymal stromal cells (MSC) possess anti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Khedoe, P. Padmini S. J., de Kleijn, Stan, van Oeveren-Rietdijk, Annemarie M., Plomp, Jaap J., de Boer, Hetty C., van Pel, Melissa, Rensen, Patrick C. N., Berbée, Jimmy F. P., Hiemstra, Pieter S.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5598950/
https://ncbi.nlm.nih.gov/pubmed/28910300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0183741
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars